Showing 4 of 4 recruiting trials for “congenital-erythropoietic-porphyria”
Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
RecruitingNCT07206095 ↗
Integrative Diagnosis for SCD and Other RADs
RecruitingNCT02964494 ↗
The Congenital Dyserythropoietic Anemia Registry (CDAR)
👨⚕️ Theodosia Kalfa, MD, PhD, Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Aug 2016View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →